[Federal Register Volume 66, Number 85 (Wednesday, May 2, 2001)]
[Notices]
[Pages 21994-21995]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-10929]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections

[[Page 21995]]

552b(c)(4) and 552 (c)(6), Title 5 U.S.C., as amended. The contract 
proposals and the discussions could disclose confidential trade secrets 
or commercial property such as patentable material, and personal 
information concerning individuals associated with the contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, SBIR Phase II: ``HIV Risk Assessment for Women in a 
Health Care Setting''.
    Date: May 4, 2001.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Richard C. Harrison, Chief, Contract Review 
Branch, Office of Extramural Affairs, National Institute of Drug 
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, 301-435-1437.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel ``Development and Manufacture of Pharmaceutical 
Products for Addiction Treatment''.
    Date: May 10, 2001.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Eric Zatman, Contract Review Specialist, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 435-1438.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel ``State and Local Epidemiology Planning and 
Information Development''.
    Date: May 22, 2001.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, 
MD 20814.
    Contact Person: Richard C. Harrison, Chief, Contract Review 
Branch, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, 301-435-1437.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: April 25, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-10929 Filed 5-1-01; 8:45 am]
BILLING CODE 4140-01-M